Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
This study investigated the early, prolonged immediate, and late‐phase reactions of dust‐mite‐sensitive subjects undergoing long‐term challenge in the Vienna challenge chamber (VCC) in terms of clinical symptoms and inflammatory mediator level patterns in nasal lavage fluids. A concentration of 70 ng Der p 1/m 3 of air (feces of Dermatopliagoides) was maintained over 8 h in the VCC. To show the clinical impact of this challenge model, the effect of a histamine H 1‐receptor antagonist that also has some antiallergic properties (loratadine) was also investigated. The study followed a doubleblind, placebo‐controlled, crossover design. Medication was given orally over 7 days before the provocation at a dose of 10 mg once daily. All 12 patients, whose dust‐mite sensitivity was confirmed by disease history, skin prick test, and RAST, completed the challenge session. The documentation of the chosen parameters was performed every 30 min. Subjective nasal and ocular symptoms were assessed via a visual analog scale of 100 mm. nasal flow was recorded by active anterior rhinomanometry, and mediator release was evaluated with nasal lavages. Clinical aspect: the whole sample population showed a rise of nasal and ocular symptom severity and a nasal flow reduction, which were perceptibly, but not significantly attenuated by active drug treatment. Mediator pattern: in each patient, prostaglandin (PG)D 2 and leukotriene (LT)C 4 levels peaked within the first 2 h of provocation, PGD 2 then moving toward baseline levels, and LTC 4 then again rising continuously. Eosinophil cationic protein (ECP) exhibited a constant level increase over the whole provocation period, and tryptase levels did not change significantly. Whereas the area under the curve values of tryptase and ECP were higher in drug‐treated patients than the placebo group, the early PGD, peak occurring during the first two challenge hours seemed to be mitigated by loratadine. These results reveal that there is no link between the clinical symptoms, the drug efficacy, and the released mediators (LTC 4, PGD 2, ECP and tryptase).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response
Castells, M., & Schwartz, L. B. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90005-x · Cited by 160
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
“The Vienna chamber was also used in mite allergy (1330).”
MethodAllergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
Gosepath, J., Amedee, R. G., & Mann, W. J. (2005) · The Laryngoscope · doi:10.1097/01.mlg.0000149682.56426.6b · Cited by 132
“To evaluate the role of allergens that are tested negative by skin or blood test but that are implicated in the patient’s history.(7) To determine whether nasal application of a specific allergen can induce ocular or bronchial symptoms in addition to nasal symptoms.”
BackgroundMarone, G., Galdiero, M. R., Pecoraro, A., Pucino, V., Criscuolo, G., Triassi, M., & Varricchi, G. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1555237 · Cited by 62
Erin, E. M., Leaker, B. R., Zacharasiewicz, A. S., Higgins, L. A., Williams, T. J., Boyce, M. J., de Boer, P., Durham, S. R., Barnes, P. J., & Hansel, T. T. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00928.x · Cited by 53
“It can also be carried out with multiple repeat allergen challenges to titrate a given symptom score (33), or with controlled allergen exposure in a challenge chamber unit (34).”
Background
Metadata
- Authors
- Horak, F., Toth, J., Hirschwehr, R., Marks, B., Stübner, U. P., Jäger, S., Berger, U., Schleinzer, K., & Günczler, P.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 1998-01
- Volume
- 53
- Issue
- 1
- Pages
- 68-72
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2033460861
- Cited by
- 33
- References
- 1
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients. https://app.cochat.ai/papers/10.1111/j.1398-9995.1998.tb03775.x
- The paper
- Horak, F., Toth, J., Hirschwehr, R., Marks, B., Stübner, U. P., Jäger, S., Berger, U., Schleinzer, K., & Günczler, P. (1998). Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients. Allergy. https://doi.org/10.1111/j.1398-9995.1998.tb03775.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.